One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial
S de Jonge, RJ de Vos, A Weir… - … American journal of …, 2011 - journals.sagepub.com
Background Achilles tendinopathy is a common disease among both athletes and in the
general population in which the use of platelet-rich plasma has recently been increasing …
general population in which the use of platelet-rich plasma has recently been increasing …
One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial.
S de Jonge, RJ de Vos, A Weir… - The American Journal …, 2011 - europepmc.org
Background Achilles tendinopathy is a common disease among both athletes and in the
general population in which the use of platelet-rich plasma has recently been increasing …
general population in which the use of platelet-rich plasma has recently been increasing …
One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy.
S de Jonge, RJ de Vos, A Weir… - American Journal of …, 2011 - search.ebscohost.com
Background: Achilles tendinopathy is a common disease among both athletes and in the
general population in which the use of platelet-rich plasma has recently been increasing …
general population in which the use of platelet-rich plasma has recently been increasing …
One-year follow-up of platelet-rich plasma treatment in chronic achilles tendinopathy: A double-blind randomized placebo-controlled trial
S de Jonge, RJ de Vos, A Weir, H van Schie… - American Journal of …, 2011 - repub.eur.nl
Background: Achilles tendinopathy is a common disease among both athletes and in the
general population in which the use of platelet-rich plasma has recently been increasing …
general population in which the use of platelet-rich plasma has recently been increasing …
One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy
S de Jonge, RJ de Vos, A Weir… - The American Journal …, 2011 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background</jats: title>< jats: p> Achilles tendinopathy is a
common disease among both athletes and in the general population in which the use of …
common disease among both athletes and in the general population in which the use of …
One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial
S de Jonge, RJ de Vos, A Weir… - American …, 2011 - researchinformation.amsterdamumc …
Achilles tendinopathy is a common disease among both athletes and in the general
population in which the use of platelet-rich plasma has recently been increasing. Good …
population in which the use of platelet-rich plasma has recently been increasing. Good …
One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial
S de Jonge, RJ de Vos, A Weir, HTM van Schie… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Achilles tendinopathy is a common disease among both athletes and in the
general population in which the use of platelet-rich plasma has recently been increasing …
general population in which the use of platelet-rich plasma has recently been increasing …
[引用][C] One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy: A Double-Blind Randomized Placebo-Controlled Trial
S DE JONGE, RJ DE VOS, A WEIR… - American journal of …, 2011 - pascal-francis.inist.fr
One-Year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy: A
Double-Blind Randomized Placebo-Controlled Trial CNRS Inist Pascal-Francis CNRS …
Double-Blind Randomized Placebo-Controlled Trial CNRS Inist Pascal-Francis CNRS …